NO139521C - Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskapsavbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon - Google Patents

Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskapsavbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon

Info

Publication number
NO139521C
NO139521C NO1648/72A NO164872A NO139521C NO 139521 C NO139521 C NO 139521C NO 1648/72 A NO1648/72 A NO 1648/72A NO 164872 A NO164872 A NO 164872A NO 139521 C NO139521 C NO 139521C
Authority
NO
Norway
Prior art keywords
semination
intermediator
preparator
australian
semen
Prior art date
Application number
NO1648/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO139521B (no
Inventor
Jean Bowler
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3967272A external-priority patent/GB1348036A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NO139521B publication Critical patent/NO139521B/no
Publication of NO139521C publication Critical patent/NO139521C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5352—Phosphoranes containing the structure P=C-

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO1648/72A 1971-05-11 1972-05-09 Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskapsavbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon NO139521C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1413971 1971-05-11
GB3967272A GB1348036A (en) 1970-05-15 1972-01-05 Transistorized vertical deflection circuit

Publications (2)

Publication Number Publication Date
NO139521B NO139521B (no) 1978-12-18
NO139521C true NO139521C (no) 1979-03-28

Family

ID=26235892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1648/72A NO139521C (no) 1971-05-11 1972-05-09 Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskapsavbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon

Country Status (26)

Country Link
JP (1) JPS5611699B1 (de)
AR (4) AR194952A1 (de)
AT (4) AT328103B (de)
AU (1) AU462755B2 (de)
BE (1) BE783292A (de)
CA (1) CA1077033A (de)
CH (3) CH596165A5 (de)
CS (1) CS192456B2 (de)
DD (1) DD99155A5 (de)
DE (1) DE2223365C3 (de)
DK (1) DK134598B (de)
EG (1) EG10752A (de)
ES (1) ES402627A1 (de)
FI (1) FI63221C (de)
FR (1) FR2137712A1 (de)
HK (1) HK50176A (de)
HU (1) HU166717B (de)
IE (1) IE37602B1 (de)
IL (1) IL39376A (de)
KE (1) KE2634A (de)
NL (1) NL164272C (de)
NO (1) NO139521C (de)
SE (4) SE399705B (de)
SU (1) SU662007A3 (de)
YU (1) YU35876B (de)
ZM (1) ZM8172A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304907A (en) * 1972-05-10 1981-12-08 The Upjohn Company Bicyclo lactone intermediates for prostaglandin analogs
DD118856A5 (de) * 1972-11-08 1976-03-20
US3966795A (en) * 1973-05-21 1976-06-29 The Upjohn Company 5-Oxa-11-deoxyphenyl- and phenoxy-substituted prostaglandin F1.sub.α analogs
US3968144A (en) * 1973-05-21 1976-07-06 The Upjohn Company 5-Oxa-11-deoxy phenyl- and phenoxy-substituted prostalandin E1 analogs
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
US4191774A (en) * 1978-01-18 1980-03-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Novel 17-aza-PGF2α derivatives and pharmaceutical compositions containing the same
US4228296A (en) * 1979-01-24 1980-10-14 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives
US4929740A (en) * 1984-10-09 1990-05-29 Syntex (U.S.A.) Inc. Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
CS264861B1 (en) * 1986-12-12 1989-09-12 Kral Josef Agent for cow natality increase
CS265947B1 (en) * 1987-06-16 1989-11-14 Kral Josef Means for farming animals' ovarian functions control
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
CS276003B6 (en) * 1988-09-28 1992-03-18 Spolana method of production of (+)-isomer of cloprostenol
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
CN102977048A (zh) * 2007-11-09 2013-03-20 阿勒根公司 具有前列腺素活性的取代环戊烷

Also Published As

Publication number Publication date
ATA539073A (de) 1975-05-15
AR194952A1 (es) 1973-08-30
ATA419172A (de) 1976-03-15
NL164272C (nl) 1980-12-15
NL7206361A (de) 1972-11-14
ZM8172A1 (en) 1973-01-22
AT328103B (de) 1976-03-10
ATA539173A (de) 1975-05-15
CH596165A5 (de) 1978-02-28
AT333447B (de) 1976-11-25
EG10752A (en) 1976-05-31
KE2634A (en) 1976-06-11
SE7504336L (de) 1975-04-15
DE2223365B2 (de) 1980-07-31
ATA538973A (de) 1975-05-15
NL164272B (nl) 1980-07-15
HK50176A (en) 1976-08-13
CH590223A5 (de) 1977-07-29
CS192456B2 (en) 1979-08-31
CA1077033A (en) 1980-05-06
IL39376A0 (en) 1972-07-26
SE7504335L (de) 1975-04-15
DK134598C (de) 1977-05-16
AT328104B (de) 1976-03-10
DE2223365C3 (de) 1981-06-04
FI63221B (fi) 1983-01-31
FI63221C (fi) 1983-05-10
CH596166A5 (de) 1978-02-28
NO139521B (no) 1978-12-18
YU125072A (en) 1981-02-28
DD99155A5 (de) 1973-07-20
AR200484A1 (es) 1974-11-15
DK134598B (da) 1976-12-06
DE2223365A1 (de) 1972-12-07
IE37602B1 (en) 1977-08-31
SU662007A3 (ru) 1979-05-05
YU35876B (en) 1981-08-31
FR2137712B1 (de) 1976-04-16
SE399705B (sv) 1978-02-27
IE37602L (en) 1972-11-11
JPS5611699B1 (de) 1981-03-16
AR197101A1 (es) 1974-03-15
FR2137712A1 (en) 1972-12-29
AR197100A1 (es) 1974-03-15
SE7504337L (sv) 1975-04-15
HU166717B (de) 1975-05-28
ES402627A1 (es) 1975-11-01
IL39376A (en) 1975-07-28
AU4202472A (en) 1973-11-15
BE783292A (fr) 1972-11-10
AT328105B (de) 1976-03-10
AU462755B2 (en) 1975-07-03

Similar Documents

Publication Publication Date Title
NO139521C (no) Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskapsavbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon
NO145380C (no) Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskaps-avbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon
ZA717799B (en) Improvements in or relating to the regulation of plant growth
DK135993B (da) 1-(4-methyl-6-hydroxy-2-pyrimidinyl)-3-methyl-pyrazolin-5-on til anvendelse som mellemprodukt ved fremstillingen af mepirizol og fremgangsmåde til fremstilling deraf.
ZA715000B (en) Agents for influencing the growth of plants
PH10160A (en) Thiazolidine derivatives and its fungicidal compositions
CS179371B2 (en) Method for preparation of new derivatives of dihydrolysergic acid and dihydroisolysergic acid.
IL40437A0 (en) New asparagic acid,derivatives and their salts and chelates and the use of the latter for regulating metal-deficiency phenomena in plants
CA947941A (en) Process for the treatment of cast bars in continuous casting plants
ZA718464B (en) Improvements in or relating to compounds of the pregnane series
ZA718071B (en) Improvements in or relating to the recovery of metal values
CA981612A (en) Process for the preparation of l-dopa and l-m-tyrosine and intermediates intended to be used at such a process
DK131602B (da) Aerosol til behandling og vedligeholdelse af tandproteser.
AU463569B2 (en) Agent forthe regulation of plant growth
CA919043A (en) Steam power plant
AU444803B2 (en) Improvements in or relating to devices for holding the legs of animals
IL38300A (en) The production of 2-aminobenzothiazole and its n-alkyl derivatives
CA850142A (en) Process for reduction of nitro compounds to corresponding oximes and ketones
IL37976A0 (en) Crystalline hydrate of trisodium d-fructose-1,6-diphosphoric acid and process for the preparation thereof
AU455307B2 (en) A process for the preparation of l-dopa and l-m-tyrosine and intermediates intended to be used at such a process
AU462012B2 (en) Improvements in or relating to cavity wall construction, and damp course elements for use therein
CA858455A (en) Composition and process for the stabilization of soil
AU2412271A (en) A process for the preparation of l-dopa and l-m-tyrosine and intermediates intended to be used at such a process
CA844074A (en) Methods of regulating steam heat power plant
AU452182B2 (en) Methods of welding together sheets to form walls, tanks, orthe like